Researchers have achieved the first demonstration in mice of using gene therapy to reverse hallmark symptoms of SYNGAP1-related disorder, a devastating condition affecting an estimated 1 million ...

In May, a historic moment in science and medicine was captured in a single photo that circulated across news outlets ...

Takeda exits cell and gene therapy development amid cost and safety concerns in Japan Takeda to divest cell and gene assets ...

At the Cell and Gene Meeting on the Mesa, a panel discussion was held on advanced therapy production and how it demands ...

Errors in a gene known to cause a serious neurodevelopmental condition in infants are also linked to the development of Parkinson's disease in adolescence and adulthood, according to new research.

The race to advance gene editing tech continues, spurred on by starry-eyed Silicon Valley investors, entrepreneurs and even pronatalists. But it is still deeply controversial.

Scientists have discovered that mutations in the EPG5 gene—known for causing the rare childhood disorder Vici syndrome—also increase the risk of Parkinson’s disease and dementia later in life.

Errors in a gene known to cause a serious neurodevelopmental condition in infants are also linked to the development of ...

BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.

Each year I like to write a post about the Nobel Prize in Physiology or Medicine. While advocating for higher standards of science in medicine we tend to spend much of our time criticizing pseudoscie ...